GB201516008D0 - OX40L antibodies and uses thereof - Google Patents

OX40L antibodies and uses thereof

Info

Publication number
GB201516008D0
GB201516008D0 GBGB1516008.8A GB201516008A GB201516008D0 GB 201516008 D0 GB201516008 D0 GB 201516008D0 GB 201516008 A GB201516008 A GB 201516008A GB 201516008 D0 GB201516008 D0 GB 201516008D0
Authority
GB
United Kingdom
Prior art keywords
ox40l antibodies
ox40l
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1516008.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kymab Ltd
Original Assignee
Kymab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kymab Ltd filed Critical Kymab Ltd
Priority to GBGB1516008.8A priority Critical patent/GB201516008D0/en
Publication of GB201516008D0 publication Critical patent/GB201516008D0/en
Priority to US14/935,937 priority patent/US9434785B1/en
Priority to MX2017011194A priority patent/MX2017011194A/en
Priority to RS20230045A priority patent/RS63903B1/en
Priority to SG10201907901X priority patent/SG10201907901XA/en
Priority to FIEP16715337.8T priority patent/FI3265123T3/en
Priority to PT167153378T priority patent/PT3265123T/en
Priority to BR112017015880A priority patent/BR112017015880A2/en
Priority to SI201631656T priority patent/SI3265123T1/en
Priority to EP22161983.6A priority patent/EP4137157A1/en
Priority to JP2017537300A priority patent/JP7094698B2/en
Priority to PL16715337.8T priority patent/PL3265123T3/en
Priority to CN202210103864.0A priority patent/CN114504652A/en
Priority to RU2017118985A priority patent/RU2725221C2/en
Priority to HUE16715337A priority patent/HUE061070T2/en
Priority to CN201680008817.0A priority patent/CN108064169B/en
Priority to LTEPPCT/GB2016/050565T priority patent/LT3265123T/en
Priority to KR1020177025436A priority patent/KR20170123637A/en
Priority to DK16715337.8T priority patent/DK3265123T3/en
Priority to CA2968642A priority patent/CA2968642A1/en
Priority to DE112016001013.3T priority patent/DE112016001013T5/en
Priority to PCT/GB2016/050565 priority patent/WO2016139482A1/en
Priority to CN202210103585.4A priority patent/CN114504651A/en
Priority to ES16715337T priority patent/ES2937020T3/en
Priority to EP16715337.8A priority patent/EP3265123B1/en
Priority to AU2016227493A priority patent/AU2016227493B2/en
Priority to HRP20230046TT priority patent/HRP20230046T1/en
Priority to SG11201704160XA priority patent/SG11201704160XA/en
Priority to US15/142,538 priority patent/US9512229B2/en
Priority to US15/333,517 priority patent/US20170037137A1/en
Priority to IL252430A priority patent/IL252430A0/en
Priority to US15/604,495 priority patent/US9868789B2/en
Priority to US15/661,584 priority patent/US9868790B2/en
Priority to MX2023006415A priority patent/MX2023006415A/en
Priority to MX2023006416A priority patent/MX2023006416A/en
Priority to AU2022202539A priority patent/AU2022202539A1/en
Priority to US17/725,228 priority patent/US20220372153A1/en
Priority to JP2022100443A priority patent/JP7472198B2/en
Ceased legal-status Critical Current

Links

GBGB1516008.8A 2015-03-03 2015-09-09 OX40L antibodies and uses thereof Ceased GB201516008D0 (en)

Priority Applications (38)

Application Number Priority Date Filing Date Title
GBGB1516008.8A GB201516008D0 (en) 2015-09-09 2015-09-09 OX40L antibodies and uses thereof
US14/935,937 US9434785B1 (en) 2015-04-30 2015-11-09 Anti-human OX40L antibodies and methods of treating graft versus host disease with the same
RS20230045A RS63903B1 (en) 2015-03-03 2016-03-03 Antibodies, uses & methods
DK16715337.8T DK3265123T3 (en) 2015-03-03 2016-03-03 ANTIBODIES, USES AND METHODS
PCT/GB2016/050565 WO2016139482A1 (en) 2015-03-03 2016-03-03 Antibodies, uses & methods
SG10201907901X SG10201907901XA (en) 2015-03-03 2016-03-03 Antibodies, uses & methods
DE112016001013.3T DE112016001013T5 (en) 2015-03-03 2016-03-03 ANTIBODIES, USES AND METHODS
PT167153378T PT3265123T (en) 2015-03-03 2016-03-03 Antibodies, uses & methods
BR112017015880A BR112017015880A2 (en) 2015-03-03 2016-03-03 antibodies, uses and methods
SI201631656T SI3265123T1 (en) 2015-03-03 2016-03-03 Antibodies, uses & methods
EP22161983.6A EP4137157A1 (en) 2015-03-03 2016-03-03 Antibodies, uses and methods
JP2017537300A JP7094698B2 (en) 2015-03-03 2016-03-03 Antibodies, uses, and methods
PL16715337.8T PL3265123T3 (en) 2015-03-03 2016-03-03 Antibodies, uses & methods
CN202210103864.0A CN114504652A (en) 2015-03-03 2016-03-03 Antibodies, uses and methods
RU2017118985A RU2725221C2 (en) 2015-03-03 2016-03-03 Antibodies, their application and methods of application
HUE16715337A HUE061070T2 (en) 2015-03-03 2016-03-03 Antibodies, uses & methods
CN201680008817.0A CN108064169B (en) 2015-03-03 2016-03-03 Antibodies, uses and methods
LTEPPCT/GB2016/050565T LT3265123T (en) 2015-03-03 2016-03-03 Antibodies, uses & methods
KR1020177025436A KR20170123637A (en) 2015-03-03 2016-03-03 Antibodies, Uses and Methods
MX2017011194A MX2017011194A (en) 2015-03-03 2016-03-03 Antibodies, uses & methods.
CA2968642A CA2968642A1 (en) 2015-03-03 2016-03-03 Antibodies, uses & methods
FIEP16715337.8T FI3265123T3 (en) 2015-03-03 2016-03-03 Antibodies, uses & methods
SG11201704160XA SG11201704160XA (en) 2015-03-03 2016-03-03 Antibodies, uses & methods
ES16715337T ES2937020T3 (en) 2015-03-03 2016-03-03 Antibodies, uses and methods
CN202210103585.4A CN114504651A (en) 2015-03-03 2016-03-03 Antibodies, uses and methods
EP16715337.8A EP3265123B1 (en) 2015-03-03 2016-03-03 Antibodies, uses & methods
AU2016227493A AU2016227493B2 (en) 2015-03-03 2016-03-03 Antibodies, uses & methods
HRP20230046TT HRP20230046T1 (en) 2015-03-03 2016-03-03 Antibodies, uses & methods
US15/142,538 US9512229B2 (en) 2015-03-03 2016-04-29 Synergistic combinations of OX40L antibodies for the treatment of GVHD
US15/333,517 US20170037137A1 (en) 2015-03-03 2016-10-25 Synergistic combinations of ox40l antibodies for the treatment of gvhd
IL252430A IL252430A0 (en) 2015-03-03 2017-05-22 Antibodies, uses and methods
US15/604,495 US9868789B2 (en) 2015-03-03 2017-05-24 Synergistic combinations of OX40L antibodies for the treatment of GvHD
US15/661,584 US9868790B2 (en) 2015-03-03 2017-07-27 Synergistic combinations of OX40L antibodies for the treatment of GvHD
MX2023006415A MX2023006415A (en) 2015-03-03 2017-08-31 Antibodies, uses & methods.
MX2023006416A MX2023006416A (en) 2015-03-03 2017-08-31 Antibodies, uses & methods.
AU2022202539A AU2022202539A1 (en) 2015-03-03 2022-04-19 Antibodies, uses & methods
US17/725,228 US20220372153A1 (en) 2015-03-03 2022-04-20 Synergistic combinations of ox40l antibodies for the treatment of gvhd
JP2022100443A JP7472198B2 (en) 2015-03-03 2022-06-22 Antibodies, Uses, and Methods

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1516008.8A GB201516008D0 (en) 2015-09-09 2015-09-09 OX40L antibodies and uses thereof

Publications (1)

Publication Number Publication Date
GB201516008D0 true GB201516008D0 (en) 2015-10-28

Family

ID=54362942

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1516008.8A Ceased GB201516008D0 (en) 2015-03-03 2015-09-09 OX40L antibodies and uses thereof

Country Status (1)

Country Link
GB (1) GB201516008D0 (en)

Similar Documents

Publication Publication Date Title
IL285375A (en) Il-8-binding antibodies and uses thereof
IL283321A (en) Anti-muc16 antibodies and uses thereof
HK1254861A1 (en) Anti-lag3 antibodies and uses thereof
HK1250238A1 (en) Anti-angptl8 antibodies and uses thereof
HK1255067A1 (en) Anti-c10orf54 antibodies and uses thereof
HK1243440A1 (en) Anti-interleukin-33 antibodies and uses thereof
IL247407B (en) Anti-egfrviii antibodies and uses thereof
HK1256381A1 (en) Anti-pacap antibodies and uses thereof
GB201503387D0 (en) Anti-carbapenem antibodies and uses thereof
IL251001A0 (en) Anti-il-25 antibodies and uses thereof
PT3292154T (en) Anti-human-her3 antibodies and uses thereof
HK1254240A1 (en) Anti-hypusine antibodies and uses thereof
GB201516008D0 (en) OX40L antibodies and uses thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)